United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72737-005_30d4f239-f37b-4b6e-b25e-043a33489011
- Product NDC
- 72737-005
- Form
- CAPSULE
- Composition / generic term
- GABAPENTIN
- Labeler
- STALLION LABORATORIES PRIVATE LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250807
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (72737-005-01) · 72737-005-01
- 100 CAPSULE in 1 BOTTLE (72737-005-02) · 72737-005-02
- 500 CAPSULE in 1 BOTTLE (72737-005-03) · 72737-005-03
- 1000 CAPSULE in 1 BOTTLE (72737-005-04) · 72737-005-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →